Stroke prevention in atrial fibrillation.
Publication
, Journal Article
Piccini, JP; Wallace, TW; Patel, MR; Becker, RC
Published in: Cardiovasc Drugs Ther
December 2011
Duke Scholars
Published In
Cardiovasc Drugs Ther
DOI
EISSN
1573-7241
Publication Date
December 2011
Volume
25
Issue
6
Start / End Page
561 / 570
Location
United States
Related Subject Headings
- Stroke
- Risk
- Practice Guidelines as Topic
- Humans
- Hemorrhage
- Fibrinolytic Agents
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Wallace, T. W., Patel, M. R., & Becker, R. C. (2011). Stroke prevention in atrial fibrillation. Cardiovasc Drugs Ther, 25(6), 561–570. https://doi.org/10.1007/s10557-011-6334-4
Piccini, Jonathan P., Thomas W. Wallace, Manesh R. Patel, and Richard C. Becker. “Stroke prevention in atrial fibrillation.” Cardiovasc Drugs Ther 25, no. 6 (December 2011): 561–70. https://doi.org/10.1007/s10557-011-6334-4.
Piccini JP, Wallace TW, Patel MR, Becker RC. Stroke prevention in atrial fibrillation. Cardiovasc Drugs Ther. 2011 Dec;25(6):561–70.
Piccini, Jonathan P., et al. “Stroke prevention in atrial fibrillation.” Cardiovasc Drugs Ther, vol. 25, no. 6, Dec. 2011, pp. 561–70. Pubmed, doi:10.1007/s10557-011-6334-4.
Piccini JP, Wallace TW, Patel MR, Becker RC. Stroke prevention in atrial fibrillation. Cardiovasc Drugs Ther. 2011 Dec;25(6):561–570.
Published In
Cardiovasc Drugs Ther
DOI
EISSN
1573-7241
Publication Date
December 2011
Volume
25
Issue
6
Start / End Page
561 / 570
Location
United States
Related Subject Headings
- Stroke
- Risk
- Practice Guidelines as Topic
- Humans
- Hemorrhage
- Fibrinolytic Agents
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants